XELPROS: payments to doctors
Payments that named XELPROS as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $785K
- Providers
- 11,084
- Transactions
- 35,208
- Average per transaction
- $22
The per-transaction average — $22 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 11,084 providers the average total is $71, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | $483,465 | 61.6% |
| SUN Pharmaceutical Industries Inc. | $301,716 | 38.4% |